Learn More About Ceftriaxone and ALS

Learn More About Ceftriaxone and ALS

Investigators on a study of ceftriaxone in amyotrophic lateral sclerosis (ALS) will host an informational webinar Tuesday,  Sept. 7, 2010

Login information for webinar ...

ALS Research Briefs

ALS Research Briefs

Short updates on ALS research: KNS-760704, FUS protein in stress granules, SOD1 and mitochondria

Expanded Ataxin 2 Genes a Major Contributor to ALS Risk

Expanded Ataxin 2 Genes a Major Contributor to ALS Risk

Small expansions in the ataxin 2 gene significantly increase the risk of developing of ALS

ALS Experts Urge Caution Regarding Head Injury Findings

ALS Experts Urge Caution Regarding Head Injury Findings

A small study has proposed that head injuries can cause an ALS-like disease, but MDA advisers say the evidence is insufficient

MDA Awards Nearly $3.5 Million in New ALS Grants

MDA Awards Nearly $3.5 Million in New ALS Grants

 Ten new MDA grants are fueling research projects designed to probe ALS from every angle 

Cover Story
Animal models — research animals with a form of the disease being studied — are one of the most important tools in ALS research today, says Fernando Vieira, director of in vivo validation at the ALS T...
Featured Articles
With the holidays just around the corner and air travel likely for many families, now is the opportune time for people with disabilities to carefully plan their sojourns. Learn from others “Traveling...
MDA has awarded 10 grants totaling nearly $3.5 million to fund research projects focused on uncovering the causes of and developing therapies for ALS. The new grants went to investigators at labs in...
The ALS TDI, an MDA-supported, nonprofit biotechnology organization in Cambridge, Mass., hosted a public webinar (online seminar) on July 27, 2010. Below is a summary of the main points of the report...
Feedback Form
Feedback Analytics